• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外成熟和脑内移植用高纯度人腹侧中脑神经前体细胞的生成。

Generation of high-purity human ventral midbrain dopaminergic progenitors for in vitro maturation and intracerebral transplantation.

机构信息

Wallenberg Neuroscience Center, Department of Experimental Medical Sciences, Lund University, Lund, Sweden.

The Danish Stem Cell Center (DanStem), Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.

出版信息

Nat Protoc. 2017 Sep;12(9):1962-1979. doi: 10.1038/nprot.2017.078. Epub 2017 Aug 31.

DOI:10.1038/nprot.2017.078
PMID:28858290
Abstract

Generation of precisely patterned neural cells from human pluripotent stem cells (hPSCs) is instrumental in developing disease models and stem cell therapies. Here, we provide a detailed 16-d protocol for obtaining high-purity ventral midbrain (VM) dopamine (DA) progenitors for intracerebral transplantation into animal models and for in vitro maturation into neurons. We have successfully transplanted such cells into the rat; however, in principle, the cells can be used for transplantation into any animal model, and the protocol is designed to also be compatible with clinical transplantation into humans. We show how to precisely set the balance of patterning factors to obtain specifically the caudal VM progenitors that give rise to DA-rich grafts. By specifying how to perform quality control (QC), troubleshooting and adaptation of the procedure, this protocol will facilitate implementation in different laboratories and with a variety of hPSC lines. To facilitate reproducibility of experiments and enable shipping of cells between centers, we present a method for cryopreservation of the progenitors for subsequent direct transplantation or terminal differentiation into DA neurons. This protocol is free of xeno-derived products and can be performed under good manufacturing practice (GMP) conditions.

摘要

从人类多能干细胞(hPSCs)中生成精确图案化的神经细胞对于开发疾病模型和干细胞疗法至关重要。 在这里,我们提供了一个详细的 16 天协议,用于获得高纯度的腹侧中脑(VM)多巴胺(DA)祖细胞,以便进行脑内移植到动物模型中,并进行体外成熟为神经元。 我们已经成功地将这些细胞移植到大鼠中; 但是,原则上,这些细胞可用于移植到任何动物模型中,并且该方案旨在与临床移植到人类兼容。 我们展示了如何精确设置模式形成因子的平衡,以获得特定的尾部 VM 祖细胞,从而产生富含 DA 的移植物。 通过指定如何进行质量控制(QC),故障排除和程序的适应,该方案将促进在不同实验室和各种 hPSC 系中实施。 为了便于实验的重现性并能够在中心之间运输细胞,我们提出了一种用于冷冻保存祖细胞的方法,以便随后直接进行移植或终末分化为 DA 神经元。 该方案不含异种衍生产品,并且可以在良好生产规范(GMP)条件下进行。

相似文献

1
Generation of high-purity human ventral midbrain dopaminergic progenitors for in vitro maturation and intracerebral transplantation.体外成熟和脑内移植用高纯度人腹侧中脑神经前体细胞的生成。
Nat Protoc. 2017 Sep;12(9):1962-1979. doi: 10.1038/nprot.2017.078. Epub 2017 Aug 31.
2
Efficiently Specified Ventral Midbrain Dopamine Neurons from Human Pluripotent Stem Cells Under Xeno-Free Conditions Restore Motor Deficits in Parkinsonian Rodents.无饲养层条件下人多能干细胞来源的高效特化腹侧中脑多巴胺神经元可恢复帕金森病模型鼠的运动障碍。
Stem Cells Transl Med. 2017 Mar;6(3):937-948. doi: 10.5966/sctm.2016-0073. Epub 2016 Oct 14.
3
Isolation of LMX1a Ventral Midbrain Progenitors Improves the Safety and Predictability of Human Pluripotent Stem Cell-Derived Neural Transplants in Parkinsonian Disease.LMX1a 腹侧中脑神经祖细胞的分离提高了人多能干细胞源性神经移植在帕金森病中的安全性和可预测性。
J Neurosci. 2019 Nov 27;39(48):9521-9531. doi: 10.1523/JNEUROSCI.1160-19.2019. Epub 2019 Oct 22.
4
Identifying the optimal developmental age of human pluripotent stem cell-derived midbrain dopaminergic progenitors for transplantation in a rodent model of Parkinson's disease.鉴定人类多能干细胞衍生的中脑多巴胺能祖细胞在帕金森病啮齿动物模型中移植的最佳发育年龄。
Exp Neurol. 2022 Dec;358:114219. doi: 10.1016/j.expneurol.2022.114219. Epub 2022 Aug 30.
5
Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions.在特定条件下从人类胚胎干细胞中生成具有区域特异性的神经祖细胞和功能性神经元。
Cell Rep. 2012 Jun 28;1(6):703-14. doi: 10.1016/j.celrep.2012.04.009. Epub 2012 May 26.
6
Engineered hydrogels increase the post-transplantation survival of encapsulated hESC-derived midbrain dopaminergic neurons.工程化水凝胶提高了包封的 hESC 源性中脑多巴胺能神经元移植后的存活率。
Biomaterials. 2017 Aug;136:1-11. doi: 10.1016/j.biomaterials.2017.05.008. Epub 2017 May 5.
7
IAP-Based Cell Sorting Results in Homogeneous Transplantable Dopaminergic Precursor Cells Derived from Human Pluripotent Stem Cells.基于内体相关蛋白分选的方法得到均一的人多能干细胞源性多巴胺能前体细胞用于移植。
Stem Cell Reports. 2017 Oct 10;9(4):1207-1220. doi: 10.1016/j.stemcr.2017.08.016. Epub 2017 Sep 21.
8
Human stem cells harboring a suicide gene improve the safety and standardisation of neural transplants in Parkinsonian rats.携带自杀基因的人类干细胞提高了帕金森病大鼠神经移植的安全性和标准化。
Nat Commun. 2021 May 27;12(1):3275. doi: 10.1038/s41467-021-23125-9.
9
Single-Cell Profiling of Coding and Noncoding Genes in Human Dopamine Neuron Differentiation.人类多巴胺神经元分化过程中编码基因和非编码基因的单细胞分析
Cells. 2021 Jan 12;10(1):137. doi: 10.3390/cells10010137.
10
Predictive Markers Guide Differentiation to Improve Graft Outcome in Clinical Translation of hESC-Based Therapy for Parkinson's Disease.预测性标志物指导分化以改善基于人胚胎干细胞的帕金森病治疗临床转化中的移植物结局。
Cell Stem Cell. 2017 Jan 5;20(1):135-148. doi: 10.1016/j.stem.2016.09.004. Epub 2016 Oct 27.

引用本文的文献

1
Advances, challenges, and opportunities of human midbrain organoids for modelling of the dopaminergic system.用于多巴胺能系统建模的人类中脑类器官的进展、挑战与机遇
EMBO J. 2025 Jul 2. doi: 10.1038/s44318-025-00494-1.
2
Three-dimensional cell-cell interactions promote direct reprogramming of patient fibroblasts into functional and transplantable neurons.三维细胞间相互作用促进患者成纤维细胞直接重编程为功能性且可移植的神经元。
Sci Adv. 2025 Jun 6;11(23):eadq7855. doi: 10.1126/sciadv.adq7855.
3
Induced Neural Progenitor Specification from Human Pluripotent Stem Cells by a Refined Synthetic Notch Platform.

本文引用的文献

1
Single-Cell Analysis Reveals a Close Relationship between Differentiating Dopamine and Subthalamic Nucleus Neuronal Lineages.单细胞分析揭示多巴胺能神经元和底丘脑核神经元谱系之间的密切关系。
Cell Stem Cell. 2017 Jan 5;20(1):29-40. doi: 10.1016/j.stem.2016.10.003. Epub 2016 Oct 27.
2
Predictive Markers Guide Differentiation to Improve Graft Outcome in Clinical Translation of hESC-Based Therapy for Parkinson's Disease.预测性标志物指导分化以改善基于人胚胎干细胞的帕金森病治疗临床转化中的移植物结局。
Cell Stem Cell. 2017 Jan 5;20(1):135-148. doi: 10.1016/j.stem.2016.09.004. Epub 2016 Oct 27.
3
Induced pluripotent stem cell technology: a decade of progress.
通过优化的合成Notch平台从人多能干细胞诱导神经祖细胞定向分化
ACS Synth Biol. 2025 May 16;14(5):1482-1495. doi: 10.1021/acssynbio.4c00742. Epub 2025 May 6.
4
Current Applications of Human Pluripotent Stem Cells in Neuroscience Research and Cell Transplantation Therapy for Neurological Disorders.人多能干细胞在神经科学研究及神经系统疾病细胞移植治疗中的当前应用
Stem Cell Rev Rep. 2025 Apr 5. doi: 10.1007/s12015-025-10851-6.
5
Synaptic deregulation of cholinergic projection neurons causes olfactory dysfunction across five fly Parkinsonism models.胆碱能投射神经元的突触失调在五种果蝇帕金森病模型中导致嗅觉功能障碍。
Elife. 2025 Apr 3;13:RP98348. doi: 10.7554/eLife.98348.
6
Somatic cell reprogramming for Parkinson's disease treatment.用于帕金森病治疗的体细胞重编程
Ibrain. 2025 Jan 4;11(1):59-73. doi: 10.1002/ibra.12189. eCollection 2025 Spring.
7
Patterning effects of FGF17 and cAMP on generation of dopaminergic progenitors for cell replacement therapy in Parkinson's disease.FGF17和cAMP对帕金森病细胞替代治疗中多巴胺能祖细胞生成的模式化作用
Stem Cells. 2025 Mar 10;43(3). doi: 10.1093/stmcls/sxaf004.
8
Pre-clinical safety and efficacy of human induced pluripotent stem cell-derived products for autologous cell therapy in Parkinson's disease.用于帕金森病自体细胞治疗的人诱导多能干细胞衍生产品的临床前安全性和有效性
Cell Stem Cell. 2025 Mar 6;32(3):343-360.e7. doi: 10.1016/j.stem.2025.01.006. Epub 2025 Feb 13.
9
Induced pluripotent stem cell-related approaches to generate dopaminergic neurons for Parkinson's disease.用于帕金森病的诱导多能干细胞相关方法来生成多巴胺能神经元。
Neural Regen Res. 2025 Nov 1;20(11):3193-3206. doi: 10.4103/NRR.NRR-D-24-00771. Epub 2024 Dec 7.
10
INTERSPECIES ORGANOIDS REVEAL HUMAN-SPECIFIC MOLECULAR FEATURES OF DOPAMINERGIC NEURON DEVELOPMENT AND VULNERABILITY.种间类器官揭示了多巴胺能神经元发育和易损性的人类特异性分子特征。
bioRxiv. 2024 Nov 15:2024.11.14.623592. doi: 10.1101/2024.11.14.623592.
诱导多能干细胞技术:十年进展
Nat Rev Drug Discov. 2017 Feb;16(2):115-130. doi: 10.1038/nrd.2016.245. Epub 2016 Dec 16.
4
Generation of serotonin neurons from human pluripotent stem cells.从人类多能干细胞生成血清素神经元。
Nat Biotechnol. 2016 Jan;34(1):89-94. doi: 10.1038/nbt.3435. Epub 2015 Dec 14.
5
Moving stem cells to the clinic: potential and limitations for brain repair.将干细胞应用于临床:脑修复的潜力与局限
Neuron. 2015 Apr 8;86(1):187-206. doi: 10.1016/j.neuron.2015.03.002.
6
Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation.通过细胞分选分离人诱导多能干细胞衍生的多巴胺能祖细胞,以实现成功移植。
Stem Cell Reports. 2014 Mar 6;2(3):337-50. doi: 10.1016/j.stemcr.2014.01.013. eCollection 2014 Mar 11.
7
Directed differentiation of forebrain GABA interneurons from human pluripotent stem cells.体外诱导人多能干细胞向 GABA 能中间神经元分化。
Nat Protoc. 2013 Sep;8(9):1670-9. doi: 10.1038/nprot.2013.106. Epub 2013 Aug 8.
8
Directed differentiation of human pluripotent cells to neural crest stem cells.人多能干细胞向神经嵴干细胞的定向分化。
Nat Protoc. 2013 Jan;8(1):203-12. doi: 10.1038/nprot.2012.156. Epub 2013 Jan 3.
9
Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions.在特定条件下从人类胚胎干细胞中生成具有区域特异性的神经祖细胞和功能性神经元。
Cell Rep. 2012 Jun 28;1(6):703-14. doi: 10.1016/j.celrep.2012.04.009. Epub 2012 May 26.
10
Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease.人胚胎干细胞衍生的多巴胺神经元在帕金森病动物模型中有效移植。
Nature. 2011 Nov 6;480(7378):547-51. doi: 10.1038/nature10648.